Peter Thiel

Angel investor and entrepreneur with publicly documented participation in atai Life Sciences financing rounds tied to psychedelic drug-development.

Investor Snapshot

Angel Investors

Classification

Angel Investor

Geography

Global

Coverage

Global

Last Verified

Apr 17, 2026

Investment Stage Focus

Series A-BGrowth / Late Stage

Investment Focus Areas

Drug Development

Investor Notes

Included under strict evidence criteria based on named participation in atai psychedelic financing rounds.

Verification

Verified

Psychedelic Focus

Explicit Psychedelic Focus

Engagement Status

Monitoring-Only

Recorded Investments

Nov 23, 2020

Series C financing (co-led) - $125m financing round

Date uses press release date.

Source Evidence

atai Series C Financing (co-led by Peter Thiel)

https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-announces-closing-125-million-series-c/

atai Convertible Note Financing (Peter Thiel named among investors)

https://ir.atai.com/news-releases/news-release-details/atai-life-sciences-announces-close-24-million-convertible-note

Founders Fund - Peter Thiel Profile

https://foundersfund.com/team/peter-thiel/